Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	33.1	19.34	18.26	20.89	0.15
Short-Term Investments	-	-	-	9.01	-
Cash & Short-Term Investments	33.1	19.34	18.26	29.9	0.15
Cash Growth	71.14%	5.91%	-38.92%	19817.22%	-87.01%
Other Receivables	0.23	0.19	0.09	0.43	0.62
Receivables	0.23	0.19	0.09	0.43	0.62
Prepaid Expenses	1.11	0.27	0.24	0.27	0.37
Total Current Assets	34.44	19.8	18.59	30.6	1.14
Property, Plant & Equipment	0.42	0.46	0.53	0.59	0.32
Other Long-Term Assets	0.08	0.01	0	0.03	-
Total Assets	34.94	20.27	19.12	31.22	1.45
Accrued Expenses	3.01	3.87	2.91	2.11	3.04
Short-Term Debt	-	-	-	-	12.52
Current Portion of Long-Term Debt	-	10.4	0.08	0.09	-
Current Portion of Leases	0.07	0.05	0.05	0.06	0.05
Current Income Taxes Payable	-	0.04	-	-	-
Other Current Liabilities	0.02	5.02	0.02	0.01	6.94
Total Current Liabilities	3.1	19.37	3.06	2.27	22.54
Long-Term Debt	-	-	8.8	9.7	-
Long-Term Leases	-	-	0.05	0.14	0.2
Other Long-Term Liabilities	-	-	-	-	0.38
Total Liabilities	3.1	19.37	11.91	12.1	23.12
Common Stock	116.36	92.91	71	77.65	23.8
Additional Paid-In Capital	20.5	17.51	16.85	-	6.19
Retained Earnings	-131	-105.5	-77.28	-74.26	-51.2
Comprehensive Income & Other	-4.16	-2.71	-2.79	16.56	-
Total Common Equity	1.7	2.22	7.79	19.95	-21.21
Minority Interest	-1.57	-1.32	-0.58	-0.83	-0.45
Shareholders' Equity	31.84	0.89	7.21	19.12	-21.66
Total Liabilities & Equity	34.94	20.27	19.12	31.22	1.45
Total Debt	0.07	10.45	8.99	9.99	12.77
Net Cash (Debt)	33.03	8.89	9.28	19.91	-12.62
Net Cash Growth	271.55%	-4.18%	-53.40%	-	-
Net Cash Per Share	0.97	0.37	0.48	1.60	-2.06
Filing Date Shares Outstanding	35.85	35.62	27.36	14.24	12.87
Total Common Shares Outstanding	35.64	27.28	21.59	14.24	6.18
Working Capital	31.33	0.43	15.53	28.33	-21.4
Book Value Per Share	0.05	0.08	0.36	1.40	-3.43
Tangible Book Value	1.7	2.22	7.79	19.95	-21.21
Tangible Book Value Per Share	0.05	0.08	0.36	1.40	-3.43
Buildings	-	-	-	0.09	0.08
Machinery	0.7	0.68	0.61	0.13	0.09
Leasehold Improvements	0.12	0.13	0.13	0.17	0.11

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q